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FOREWORD 
This is a report on the Ombudsman’s investigation of a complaint from a pharmacist about the 
Department of Health (DoH) and the Department of Human Services (DHS). The complainant 
contacted our office because he believed that a neighbouring pharmacy had been incorrectly 
approved to dispense medications under the Pharmaceutical Benefits Scheme (PBS). He told 
us the neighbouring pharmacy had relocated from its original site to one closer to his 
pharmacy than the rules allowed and this affected the viability of his business. He had 
unsuccessfully attempted to find out from DoH and DHS how this had happened, and was 
frustrated in his attempts to obtain a resolution. 
 
The approval process, jointly administered by DoH and DHS, relies upon the pharmacist 
applying for approval to provide evidence of the distances between their new location, old 
location and any other nearby pharmacies. There was an error in the measurement of the 
distances between the pharmacies. This error had come to the attention of the DoH before the 
approval was finalised, but the information was not relayed to DHS, which granted the 
approval without knowing that the application did not meet the location requirements. 
 
We found problems in the design of the pharmacy approval program, which focussed primarily 
on the interests of the applicant pharmacist without considering how to protect the interests of 
other pharmacies in the area. The program was delivered by two separate agencies, without 
sufficient regard to the need to share information in a timely way to ensure the integrity of the 
scheme. When it became apparent to DoH that DHS had made a decision based on wrong 
information, it initially failed to consult with DHS about how to put things right. In our view, 
DoH responded to the mistake in an inappropriately defensive way. Finally, when someone 
affected by the error complained about it, they were met by an unwillingness to explain or 
admit fault, and told their only option was to go to court. 
 
We were unable to obtain a remedy for the complainant. However, DoH agreed that, if the 
complainant makes a claim for compensation including evidence of loss, it will refer that claim 
to its Minister for consideration.  
 
We note that DoH has already implemented changes to its administrative procedures to 
address some of the problems that this complaint revealed. At the conclusion of this report we 
make four recommendations that we believe will further strengthen those arrangements, and 
provide a more open and responsive complaint process. 
 
While this complaint is about a very particular set of factual circumstances, we believe it holds 
broader lessons for Commonwealth agencies about the importance of proper program design, 
sharing information necessary to ensure proper outcomes and about service recovery 
arrangements when things go wrong. 
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EXECUTIVE SUMMARY 
This is a report on our investigation of a complaint about the administrative program for the 
approval of pharmacists to dispense medications which are subsidised by the government 
under the Pharmaceutical Benefits Scheme (PBS), from pharmacies in particular locations. 
In December 2012 the Ombudsman’s office received a complaint from a pharmacist about an 
approval to dispense PBS medications from a pharmacy which had recently relocated to a site 
about 23 metres closer to the complainant’s pharmacy than the minimum 500 metres that the 
pharmacy location rules allowed. He said the proximity of the two pharmacies affected the 
viability of his business. 
The pharmacy location rules were determined by the Minister for Health under the National 
Health Act 1953 and reflected the five yearly Community Pharmacy Agreements between the 
Commonwealth and the Pharmacy Guild of Australia. 
Under the program, applications were received by the Department of Human Services-
Medicare (DHS) and were sent to the Secretariat of the Australian Community Pharmacy 
Authority (ACPA) in the Department of Health (DoH) for the ACPA to make a recommendation 
under the rules. The ACPA’s recommendation was then sent back to DHS, where the 
delegate of the Secretary of DoH made the final decision. 
Our investigation concluded: 
• The complainant did not have an opportunity to comment on the proposed decision before 
it was made. Although this was not a legal precondition for the making of the decision, it 
would have been good administrative practice to have provided such an opportunity. 
• The ACPA made a recommendation on the basis of a survey provided by the applicant 
which, although prepared by a surveyor with a diploma, was not prepared by a registered 
surveyor and which contained a material error regarding the distances. Had an accurate 
survey been before the ACPA, the application would not have satisfied the rules. 
• The ACPA Secretariat became aware of the possibility of an error, by way of a conflicting 
survey related to another application, after the recommendation had been sent to the 
delegate of the Secretary of DoH, located in DHS, but before the final decision was made. 
• The ACPA Secretariat sought legal advice and considered whether it should act on the 
information, but failed to do so before the decision was made by the delegate. While the 
Ombudsman accepts that there was only a short period of time in which to act on the 
information, we have concluded that the ACPA Secretariat should have at least advised 
the delegate in DoH that there was a material concern with the recommendation within 
that short period of time. 
• The ACPA Secretariat failed to take any further service recovery action after it was 
advised that the delegate’s decision had been made until the complainant raised the 
matter with it. This was the case, even though the ACPA Secretariat did not know whether 
or not the relocating pharmacist had acted in reliance upon the decision at that time. 
• The ACPA Secretariat sought external legal advice and advised the complainant that he 
was not entitled to a statement of reasons under the Administrative Decisions (Judicial 
Review) Act 1977. In the Ombudsman’s view, that advice was incorrect. 
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• DHS considered the complainant’s complaint and sought legal advice about what could be 
done. However, by the time it did so more than 6 months had elapsed since the decision 
had been communicated to the relocating pharmacist. The Ombudsman’s office has not 
received any evidence indicating that DHS was told that the ACPA Secretariat was aware 
of the error before the decision was made, until more than 6 months after the decision had 
been made. 
• Neither the ACPA Secretariat in DoH nor DHS advised the complainant of the fact that the 
ACPA had been aware of the error independently of survey evidence that the complainant 
himself had later provided. Nor did either agency admit or explain the error or apologise to 
the complainant. [The agencies sought legal advice and advised the complainant …] that 
the decision was lawful, regardless of after acquired evidence showing its factual basis to 
be incorrect, and referred him to the Federal Court. 
The Ombudsman has made four recommendations. 
The first recommendation recognises that the relevant legislation gave very little scope for the 
correction of an erroneous decision by administrative means, once the decision had been 
communicated to the applicant and acted on. In such contexts the administrative processes 
leading up to a decision should include steps to minimise error, such as consultation 
processes, regardless of whether these are legal preconditions to the making of the decision. 
We note DoH has already taken steps in relation to the quality of survey evidence it will now 
accept. 
The second recommendation concerns the contribution of the cross agency design of the 
decision making process to the resulting decision which did not meet the objectives of the 
rules. The process unnecessarily fragmented access to information which was relevant to the 
decision. In the case at hand, officers hesitated to inform other officers involved in the 
decision making process that there was a significant matter regarding the recommendation 
because, while operating under the same Act and program, those other officers were located 
in a different agency and they were cautious about the possible application of the secrecy 
provisions of the National Health Act 1953 and the Privacy Act 1988.  
Few programs are amenable to perfect delivery. Good administration recognises this fact and 
each program should have a service recovery plan encompassing the handling of complaints. 
The third recommendation concerns the need for a joint service recovery process should the 
program continue to be delivered across more than one agency. If, in future, the program is 
delivered by a single agency, then a service recovery process should be devised in relation to 
the program.  
The fourth recommendation concerns the agency culture that we believe underscored DoH’s 
overly cautious and defensive approach to the problem, which undermined the overall 
objective of the program. The best service recovery arrangements will not be effective if the 
staff in an agency are not encouraged and supported to identify and take responsibility for 
fixing errors. Even where the agency believes it is unable to remedy a mistake, it should be 
prepared to provide an explanation and an apology. We have recommended that steps be 
taken to support a robust service recovery culture within DoH. 
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PART 1—THE OMBUDSMAN’S INVESTIGATION 
1.1 The information below sets out the Ombudsman’s opinion as to the facts of the 
complaint as a result of our investigation. 
Background 
The PBS and pharmacy location rules 
1.2 The Pharmaceutical Benefits Scheme (PBS) provides for the dispensing of 
medications, as listed in an instrument made under the National Health Act 1953 (the Act), at 
a government subsidised cost. The Act defines these medicines as ‘pharmaceutical benefits’. 
A pharmacist who has not been approved to supply pharmaceutical benefits from a particular 
pharmacy cannot supply the listed medicines from that location and claim the subsidy. 
1.3 The First Community Pharmacy Agreement (1990-95) between the Commonwealth 
and the Pharmacy Guild of Australia included rules about the location of pharmacies in 
response to the emergence of uneven concentrations of pharmacies across Australia during 
the 1980s which impacted on the cost of the PBS program, access for consumers and viability 
of businesses.1 The Fourth Community Pharmacy Agreement (2005-10) included the terms of 
agreement on new pharmacy location rules which were determined by the Minister in 2006 
and are referred to below. 
1.4 The objectives of the new pharmacy location rules were set out at item 25.1 of the 
Fourth Agreement as follows: 
…to ensure: 
a. All Australians have access to PBS medications; 
b. A commercially viable and sustainable network of community pharmacies dispensing PBS medicines; 
c. Improved efficiency through increased competition between pharmacies; 
d. Improved flexibility to respond to the community need for pharmacy services; 
e. Increased local access to community pharmacies for persons in rural and remote regions of Australia; 
and  
f. Continued development of an effective, efficient and well-distributed community pharmacy network in 
Australia. 
 
1.5 The Fifth Community Pharmacy Agreement (2010-2015), in place at the time of the 
events in this report, did not alter arrangements regarding the pharmacy location rules made 
under the Fourth Agreement. 
1.6 At the time of the events giving rise to this report, s90 of the Act provided that the 
Secretary of the Department of Health may, upon application by a pharmacist, approve that 
pharmacist for the purpose of supplying pharmaceutical benefits at particular premises. 
Before doing so, the Secretary was required to refer specified applications to the Australian 
Community Pharmacy Authority (the ACPA) for recommendation. The Secretary could decline 
to approve an application recommended for approval by the ACPA, but the Secretary could 
not approve an application where the ACPA had not also recommended approval. 
1.7 Section 99L of the Act required the Minister to determine rules under which the ACPA 
was to make its recommendations. The rules determined in the National Health (Australian 
Community Pharmacy Authority Rules) Determination 2006 (the Rules) reflected the Fourth 
1  Regulation Impact Statement, National Health Amendment Bill (No.1) 2000 Explanatory 
Memorandum, pp 4-6.  
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Community Pharmacy Agreement and made provisions about the location of the premises at 
which pharmaceutical benefits could be supplied.  
1.8 Where a pharmacist sought to relocate their existing approved pharmacy location, rule 
105 specified the permissible distances from the new site of the pharmacy to both its original 
location and the location of other approved pharmacies, for approval to be recommended by 
the ACPA.  
Pharmacy C and Mr C’s complaint 
1.9 From June 2011 Mr C was the proprietor of a pharmacy (pharmacy C) approved to 
dispense medications under the PBS at a commercial and residential precinct in NSW (the 
precinct). 
1.10 In December 2012 Mr C complained to the Ombudsman about the approval of another 
pharmacy (pharmacy X), which had relocated within the precinct, to provide PBS medications 
under rule 105. He believed that pharmacy X did not comply with the relocation distances set 
out in the Rules and was neither the required distance from its original location nor from 
pharmacy C. Mr C complained that relocated pharmacy X’s proximity to pharmacy C impacted 
on his business. 
Approval process 
1.11 The approval process required submission of an application, accompanied by survey 
evidence, to the Pharmacy Program area of the Department of Human Services Medicare 
program (DHS), which then provided the application to the ACPA Secretariat in DoH. The 
Secretariat listed the application for recommendation by the ACPA, the members of which are 
appointed by the Minister for Health. The ACPA’s recommendatory powers required it not to 
make a recommendation to approve the application unless the distance requirements were 
met. The ACPA would then send its recommendation, along with the application, back to the 
Secretary of DoH’s delegate under the Act who was located in DHS. The Secretary of DoH’s 
delegate then made the final decision whether or not to approve the application.  
Pharmacy X 
1.12 On 18 July 2011, Mr X (the proprietor of pharmacy X) lodged an application under rule 
105 to dispense PBS medications from his relocated pharmacy. Mr X’s application was 
accompanied by a survey report setting out the distances between the original location of his 
pharmacy and its new location and also between the new location and Mr C’s pharmacy. The 
survey report indicated the surveyor held a relevant diploma but the survey was not, and did 
not purport to be, prepared by registered surveyor. This was not a requirement at that time, 
according to the Pharmacy Location Rules Applicant’s Handbook (the Applicant’s Handbook).  
We note that the Applicant’s Handbook does require that the information provided with an 
application is accurate and up-to-date, and also advises that provision of false or misleading 
information is an offence under the Criminal Code 1995. 
Making a decision on Mr X’s application 
1.13 While consultation with other surrounding pharmacies was not required by law, we 
understand that the ACPA often does so, except where the identity of the applicant would be 
obvious. The Applicant’s Handbook explained the consultation process as ‘standard practice’ 
(though noting that ‘the Authority is not required or obliged to seek comments from nearby 
pharmacists’) and that, once it has made a recommendation about an application, the ACPA 
will write to any pharmacist who provided comments on the application to advise the 
outcome.2 However, the ACPA did not afford any surrounding pharmacies an opportunity to 
2  P.8. See Appendix. 
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comment on Mr X’s application. DoH advised that this was because the applicant’s identity 
would be obvious in short distance relocations, potentially breaching s135A of the National 
Health Act 1953. 
1.14 On 30 September 2011 the ACPA recommended approval of the application to supply 
PBS medicines from the relocated pharmacy X on the basis that it met rule 105. This 
recommendation was sent to the Secretary’s delegate in DHS. 
Pharmacy Y 
1.15 Meanwhile, a third pharmacist (Mr Y) moved to the original premises of pharmacy X 
and sought approval to dispense medicines under the PBS from that location (new pharmacy 
Y). The ACPA decided not to recommend approval for pharmacy Y on the basis of the 
location rules. Mr Y sought review of this decision by the Administrative Appeals Tribunal 
(AAT). In the course of those proceedings, Mr Y lodged a survey which contradicted the 
distance between pharmacy Y (the original premises of the relocated pharmacy X) and 
pharmacy X’s new site as shown by the survey that accompanied Mr X’s application. 
1.16 For the purposes of the AAT proceedings, on 8 November 2011 DoH Legal Services 
sought instructions from the Pharmacy Location Rules section within DoH, which also 
operates as the ACPA Secretariat.3 An officer in that section noted the contradiction between 
the survey that Mr Y submitted in his AAT proceedings and the survey Mr X submitted in 
support of his application for the approval of pharmacy X. 
1.17 On 9 November 2011, in comments in response to DoH Legal Services, the officer 
noted: 
If the straight line distance measurement between the proposed premises and approved premises at 
[pharmacy X’s new location], is correct at 1.56km, then the recommended (approved) applicant for 
[pharmacy X’s new location] would have failed under Rule 105. 
1.18 That is, the survey provided by Mr Y showed that the relocated pharmacy X was too 
far from its original site (1.56 km rather than 1.5 km), and it later transpired too close to 
pharmacy C (477m rather than 500m), to qualify for approval under Rule 105. 
Dealing with the contradictory surveys 
1.19 On 9 November 2011 the Pharmacy Location Rules section/ACPA Secretariat 
requested that an independent survey be obtained through the Australian Government 
Solicitor (AGS).  
1.20 The independent survey was consistent with Mr Y’s survey and was provided by the 
AGS to the ACPA Secretariat at 11.32 am on 23 December 2011 with the [comment…] that it 
‘must cast doubt on the earlier (unrelated) application to relocate from [Mr X’s original 
premises]’. 
1.21 The ACPA Secretariat and DoH Legal Branch consulted AGS by telephone the same 
day (23 December 2011). This was the last working day before Christmas in 2011. Owing to a 
Public Service holiday observed by DoH on 28 December 2011, the next working day for DoH 
was 3 January 2012. 
1.22 No records of the advice AGS gave DoH on 23 December 2011 that were made on 
that date have been uncovered by our investigation. DoH reports that it was advised that it 
3  The same DoH officer (Officer Q) signs correspondence on behalf of the Secretariat and also on 
behalf of the Pharmacy Location Rules section of DoH. 
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could not provide the results of the independent survey to the Secretary’s delegate in DHS, 
until AGS had the opportunity to consider the matter further and that written advice would be 
provided on 4 January 2012.  
Approving Mr X’s application in respect of pharmacy X  
1.23 DHS did not observe the Public Service holiday on 28 December 2011. On 
28 December 2011, the delegate in DHS accepted the ACPA’s recommendation in respect of 
pharmacy X and granted the approval to dispense medications under the PBS from that site.  
1.24 On 3 January 2012 AGS sent an email to DoH [reflecting …] its understanding that the 
Secretary’s delegate in DHS had not yet approved the application. 
A missed opportunity 
1.25 On 4 January 2012 AGS advised DoH that it would be prudent for the ACPA 
Secretariat to advise the relevant delegate in DHS that the ACPA had new evidence relevant 
to the applicant’s application for the relocated pharmacy and was considering how to proceed. 
AGS advised that the DHS delegate may wish to hold off making any decision until the 
beginning of the following week. 
1.26 On 5 January 2012, the Secretariat contacted DHS and discovered the decision to 
approve the application had already been made by the delegate and advised AGS 
accordingly. 
1.27 In an email of 5 January 2012 AGS advised DoH that it would cease preparation of the 
requested advice [but made relevant passing comments ....] 
1.28 [Subsequently DoH concluded that …] the Secretary’s approval in this case was […] 
valid.  
1.29 Our investigation found no further evidence of any discussion between DoH and AGS 
about whether at that point in time the erroneous approval might be recalled or corrected, 
even though the successful applicant may not have acted on it in the few days that had 
elapsed since 28 December 2011. Nor was there evidence of consideration of any impact the 
incorrect approval decision might have on other pharmacies located in the precinct.4 
Mr C’s efforts to resolve his complaint with DOH and DHS 
1.30 In February 2012, Mr C discovered from conversations with his customers that 
pharmacy X had begun dispensing PBS medications from its new location. Mr C’s lawyer 
wrote to the Secretariat on 13 February 2012 and requested a statement of reasons under the 
Administrative Decisions (Judicial Review) Act 1977.  
1.31 The Secretariat sought legal advice and, on 20 February 2012, declined to provide a 
statement of reasons to Mr C’s lawyer by letter signed by Officer Q, advising that Mr C was 
not a person aggrieved by the decision and as such was not entitled to receive a statement of 
reasons for it. […] We consider that advice was incorrect.5 
1.32 The Secretariat did not provide any information to Mr C about either the application for 
approval of pharmacy X or Mr Y’s application for approval for pharmacy Y, or the surveys in 
4  Our investigation found [evidence that options for undoing a recommendation had been considered 
possible on a previous occasion, where, among other preconditions, the decision has not been 
notified….] 
5  Pharmacy Guild of Australia v ACPA, [FCA Branson, J 1996]. The decision in respect of the ‘person 
aggrieved’ point had not been superseded. 
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support of those applications. DoH says the Secretariat [sought legal advice and] considered 
that the information was confidential under s135A of the Act […].  
1.33 Mr C obtained information about the distance between pharmacies C, X and Y from 
independent observation. He then commissioned his own survey, which he provided to the 
Secretariat on 28 March 2012 and to DHS on 2 April 2012.  
1.34 On 19 April 2012, Mr C also wrote to the Minister for Health about his belief that the 
application concerning pharmacy X should not have been approved. 
1.35 On 5 April 2012 the Secretariat responded by email advising that the ACPA was 
satisfied, on the evidence available to it on the date it made its recommendation, that the 
pharmacy X application met the requirements of rule 105 of the Rules and that the ACPA was 
unable to reconsider its decision regardless of any new information. The Secretariat’s 
response noted that decisions of the ACPA are reviewable by the Federal Court on a point of 
law and recommended Mr C seek his own independent legal advice before proceeding. 
1.36 Thereafter Mr C contacted DHS at regular intervals to follow up his complaint to that 
agency. 
1.37 DHS conducted a site visit to the precinct on 24 May 2012. DHS wrote to Mr X [ or his 
representatives on four occasions in 2012 from 28 May 2012 …] 
1.38 Following a request from Mr X’s representatives that an amicable resolution be 
achieved, DHS wrote to them again on 27 September 2013 and 17 October 2013. DHS 
suggested in the latter correspondence that Mr X approach the Pharmacy Guild of Australia 
for the purposes of mediating between himself and Mr C.  
1.39 We understand that Mr X responded to DHS’ letter, […and] he raised concerns that Mr 
C had not objected during the approval process. We consider this demonstrates that Mr X had 
assumed that Mr C, as the proprietor of pharmacy C in the precinct, would have been advised 
of his application to dispense PBS medications from pharmacy X before the decision was 
made.  
1.40 On 4 June 2012, Officer Q responded to Mr C on behalf of the Minister for Health. The 
response noted that the ACPA can only consider evidence before it at the time it considers an 
application, regardless of any new information that subsequently becomes available. The 
letter advised that under the Rules the ACPA must satisfy itself that, on the day it considers 
an application, the requirements of the particular Rule under which the application was made 
are met; that there is no provision for the ACPA to remake its recommendation; that DHS has 
the responsibility of ensuring compliance with the PBS program including the granting and 
cancelling of approval and that Mr C’s correspondence has been referred to DHS. The letter 
does not contain any information about the independent survey commissioned by the 
Secretariat and does not admit any error had been made. 
1.41 On 4 June 2012, Officer Q of DoH also wrote to DHS about the referral of Mr C’s 
complaint, enclosing a copy of the independent survey that AGS commissioned at DoH’s 
request. The survey included photographs dated 14 December 2011. Representatives of DHS 
and DoH also discussed the matter at monthly meetings about Pharmacy Location Rules 
Issues. 
1.42 On 18 June 2012 DHS sought legal advice [… on the facts known to it, which did not 
include the date of receipt of the independent survey] concerning the lawfulness of the 
approval decision and whether it might be reconsidered. […abridged…] [DHS concluded] the 
incorrectly made decision could not now be remedied […].  
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1.43 On 13 July 2012, DHS asked DoH to clarify whether the usual consultation processes 
had been undertaken in the approval process for pharmacy X. DHS referred to Mr X’s 
question about why Mr C had not raised his concern about the distances between pharmacy 
C and the pharmacy X at an earlier time. 
1.44 Officer Q responded on 16 July 2012 that DoH had not, and was not obliged to, 
consult the surrounding pharmacists. In a separate email the same day Officer Q confirmed 
that DoH had received the independent survey report on 23 December 2011. 
1.45 On 17 July 2012 DHS sought further legal advice [and concluded it would not be 
appropriate to take any action unless the complainant…] or some other person, challenged 
the decision in a court. […]. 
1.46 On 31 July 2012 the Acting National Manager, Ministerial Coordination and 
Parliamentary, in DHS advised Mr C that DHS was looking into his complaint about the 
approval of pharmacy X. 
1.47 On 17 August 2012 DHS wrote to Officer Q regarding its proposed response to Mr C’s 
complaint, advising: 
[Mr C] will also be advised that at the time the delegate assessed the application there was no indication that 
any information was incorrect, and therefore the Secretary’s decision was correctly made and is valid and it 
will be suggested that he seek further legal advice through his legal representative. 
1.48 In our view, it was incorrect to say that there was ‘no indication that any information 
was incorrect’ on 28 December 2011. While the incorrect information may not have been 
apparent to the delegate in DHS, it was known to the DoH Secretariat on that date. However, 
DHS has advised us that it was responding on its own behalf and not on behalf of DoH. 
1.49 On 28 August 2012 the National Manager, DHS, replied to Mr C that ‘[a]t the time of 
approval, the information before the delegate of the Chief Executive Medicare on behalf of the 
Secretary of the Department of Health and Ageing met all of the legislative requirements 
under section 90 of the National Health Act 1953’ and that Mr C may wish to seek further 
advice through his legal representative. 
1.50 In September 2012 Mr C met Mr Y, the proprietor of pharmacy Y. Mr Y informed Mr C 
of matters relating to Mr Y’s approval application. Mr Y told Mr C that Mr Y’s survey had 
contradicted Mr X’s survey and had been provided to the ACPA in 2011. 
1.51 On 24 October 2012, after meeting Mr Y, Mr C lodged an application with the AAT for 
review of DHS’ decision to approve Mr X’s application. However, the AAT informed Mr C that 
it could only review decisions that declined approvals and his complaint concerned the giving 
of an approval. The AAT told Mr C he would need to apply to the Federal Court, which he 
advised [would be costly]. 
Ombudsman’s consideration of Mr C’s complaint  
1.52 While we were considering Mr C’s complaint, in October 2013, the Federal Court 
decided Kastrinakis v ACPA & Ors [2013] FCA 995, concerning the ACPA’s recommendation 
in respect of an unrelated pharmacy. The court accepted an argument on the application of 
jurisdictional error to a recommendation for approval by the ACPA based upon incorrect 
distance information. In particular, Davies J distinguished the Australian Pharmacy Guild case 
[see footnote 5] on the basis of the High Court [decision in Enfield City Corporation v 
Development Assessment Commission6] and the new Rules, and concluded that meeting the 
6 [2000] HCA 5. 
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distance requirement was a jurisdictional fact. This meant the approval in that case was not 
valid because the distance requirement was not met. It follows that the decision to approve 
pharmacy X, about which Mr C has complained, might have been open to a similar challenge. 
It is acknowledged however that neither DoH nor DHS would have had the benefit of this 
judgement at the relevant time and that the agencies relied on legal advice […]. 
Proposing a remedy for Mr C 
1.53 In December 2013, the Ombudsman wrote to DoH to communicate his preliminary 
view about Mr C’s complaint. DoH did not dispute our outline of the facts, but does not agree 
that its actions were unreasonable, that defective administration had been established or that 
any error made by it caused loss for Mr C.  
1.54 On 3 March 2014, after considering the DoH’s response to his preliminary view, the 
Ombudsman wrote again to the DoH. The Ombudsman made a recommendation under 
paragraph 92 of the Finance Circular 2009/09 that DoH consider paying Mr C compensation 
for detriment caused by defective administration.  
1.55 DoH’s response to the Ombudsman indicated that it remained of the view that its 
actions were not unreasonable, did not amount to defective administration and that it did not 
agree that any error made by it caused loss to Mr C. However, DoH advised it would put any 
application with evidence of loss made by Mr C to its Minister for consideration. We conveyed 
this information to Mr C. 
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PART 2—SYSTEMIC WEAKNESSES 
2.1 In our view, the design of the approval process for pharmacies to dispense PBS 
medications made it vulnerable to errors of the type that occurred in this case. The 
weaknesses included: 
• cross agency decision-making combined with uncertainty about whether s135A of the 
National Health Act permitted relevant information to be transferred between different 
participants in the same process 
• the apparent inability to correct errors combined with a low evidentiary threshold (an 
unregistered surveyor’s report prepared for the applicant)  
• the absence of consultation with nearby pharmacies or other informed stakeholders.  
2.2 Taken together, these deficiencies left little opportunity for checks and balances to 
prevent errors and no scope for service recovery. Moreover, timely action was not taken when 
the error was discovered. Subsequently, when a person affected by the error (Mr C) 
complained about it, the agencies responded in a defensive manner which, in turn, prolonged 
the complaint experience and impeded Mr C’s capacity to resolve the matter. 
Consultation with nearby pharmacies  
2.3 On 13 April 2012 the Pharmacy Guild of Australia wrote to the Pharmacy Location 
Rules Section of DoH regarding ‘the process of notifying nearby approved pharmacies when 
an application for approval to supply pharmaceutical benefits is lodged’. The Guild raised 
concerns that there was no guarantee that the ACPA would write to all nearby pharmacists 
who might be affected. The result was that these pharmacists did not have the opportunity to 
supply evidence which may have assisted the ACPA, leaving some to take costly legal 
proceedings which might have been avoided by an opportunity to comment on the application. 
The Guild also suggested that where an application concerned the measurement of a 
distance, which was close to the allowable distance, the ACPA should seek advice from a 
second independent surveyor at the cost of the applicant. 
2.4 DoH responded on 1 May 2012. It stated that it could not guarantee to write to all 
surrounding pharmacists first, because its database was not able to identify all of the contact 
addresses of all pharmacies in a location; and, secondly, the ACPA secretariat does not have 
real time data to capture surrounding pharmacies that have recently been approved. 
However, it advised: 
Where the ACPA considers that a distance requirement for a particular application is close or 
questionable (whether raised by a surrounding pharmacist or not), the decision on the application is 
usually deferred and an independent survey is obtained at the Department’s expense. 
… 
While the majority of comments from surrounding pharmacist (sic) do not provide relevant information for 
the ACPA and the worth of the process has been questioned, there are cases where surrounding 
pharmacists do provide the ACPA with significant information which informs the decision-making process. 
… 
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In addition … for Rule 1257 - short distance relocation (more than 1 km), to enable a surrounding 
pharmacist to comment would require the identification of the existing premises and therefore potentially 
the identification of the owner. This would provide specific information about the commercial plans / 
activities of the applicant to the surrounding pharmacies. To provide such information may be in breach of 
the secrecy provisions of the National Health Act 1953. 
2.5 DoH also advised that it would ‘continue its efforts to ensure, but cannot guarantee8, 
that comments are sought from surrounding pharmacies, where relevant.’  In doing so, DoH 
advised that it is required to have regard to the secrecy provisions under s135A of the 
National Health Act when considering seeking views from nearby pharmacies. 
2.6 In the case of the approval of pharmacy X, consultation with the surrounding 
pharmacists would have notified Mr C who could then have raised his concerns prior to the 
decision being made. Moreover, it is apparent that the applicant and the Secretary’s delegate 
in DHS expected that any objections would be made in this way. 
2.7 In relation to the DoH concerns that it did not have the data to guarantee that every 
potentially affected pharmacist would be consulted and that it might breach the Act by so 
doing, we do not consider these concerns are necessarily impediments. To demonstrate 
compliance with rule 105, Mr X had identified pharmacy C in his application. Moreover, most 
approved pharmacies, including pharmacy C, would appear to be on the Pharmacy Approval 
database and there are other reasonable searches that might be made to enable their 
identification. An applicant pharmacist could be required to identify surrounding pharmacies in 
their application for approval. In our view an administrative process, to obtain the consent of 
applicants to the release of such information as is necessary for consultation with potentially 
affected pharmacists and that does not conflict with the Act, could be devised notwithstanding 
the secrecy provisions in the legislation. 
Recommendation 1 
A consultation process with potentially impacted pharmacies is developed to enable the 
receipt of comments on an application prior to the making of a recommendation or decision on 
that application. 
Inability to correct errors combined with low evidentiary threshold 
2.8 It was critical to the ACPA’s recommendation to approve the dispensing of PBS 
medications from pharmacy X, that the distances between the locations of the pharmacies 
were accurately measured. Yet, in this case the ACPA accepted evidence of the distances 
prepared by a person instructed by the applicant and who was not a registered surveyor. DoH 
has pointed out that the survey letter head indicated the surveyor held a diploma in surveying. 
However, it is registration rather than qualification that provides access to the profession’s 
complaints body. DoH also said that it relied on a statement in its application materials to the 
effect that the provision of false or misleading information is an offence under the Criminal 
Code 1995. However this is no protection against ordinary mistakes which, in the 
Ombudsman's experience, are more common than an intention to mislead. The applicant had 
a right of appeal to the AAT in the event that an error was made resulting in a decision not to 
recommend approval of his application. However, if an error was made in the applicant’s 
favour, which might impact on surrounding businesses, there was no right of appeal to the 
AAT and the legal options for correcting an error after approval was given were limited and 
costly. 
7  The 2006 Rules had been revoked by this time and replaced with rules affecting applications made 
from 18 October 2011. 
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2.9 In this case, the survey submitted by Mr X showed the relocated premises to be 
1386m from the original site by straight line and 515m from pharmacy C by straight line. The 
requirements to meet rule 105 were that the premises be between 1000m and 1500m from 
the original site and over 500m from another approved pharmacy. We note the 15m, by which 
Mr X’s survey represented that the new location complied, did not trigger the ACPA 
Secretariat to request its own survey or seek further evidence. 
2.10 In our view, the decision-maker’s level of satisfaction as to the facts on which an 
administrative decision is based should increase in proportion to the consequences of that 
decision, in particular where the decision cannot be readily corrected. In this regard we 
acknowledge DoH’s advice to us on 25 February 2013 in response to our investigation, that 
the ACPA is now more cautious when considering survey reports: 
‘…whilst there is no requirement for the Authority to gather its own evidence, where there is any doubt, 
the Authority will continue to commission its own independent survey report. In addition, the Authority will 
now only consider a survey report that has been prepared by a registered surveyor. This allows for any 
significant discrepancies in survey reports to be referred to the Survey Board in the relevant state.’ 
2.11 DoH also advised that it would consider whether ‘an amendment to the (National 
Health) Act could allow corrective or other action to be taken where there appears to have 
been a gross error of fact in the evidence provided with an application’. 
Cross agency decision-making process 
2.12 While applications were received and registered by DHS, they were sent to the 
Secretariat in DoH for handling before and after consideration by the ACPA. Thereafter the 
same applications accompanied by the ACPA recommendations were returned to DHS for 
consideration by the delegate of the Secretary of DoH. Yet the Secretariat hesitated in 
informing the delegate of the existence of the independent survey that suggested an earlier 
ACPA recommendation was based upon incorrect evidence. The Secretariat also delayed 
suggesting to DHS that it postpone considering the ACPA’s recommendation until a material 
issue which had come to the Secretariat’s attention was clarified. 
2.13 Despite the Secretariat’s officers’ awareness, based on two surveys, that Mr X’s 
survey (on which the ACPA’s recommendation was based) was more likely than not incorrect, 
they exercised a misplaced level of risk adversity regarding the provision of information about 
the independent survey to the delegate in DHS. Instead the officers sought legal advice and, 
while no record was made on that day, DoH reports the officers [understood …] they could not 
inform the delegate in DHS until further advice was provided.  
2.14 In our view it is difficult to see how s135A of the Act could prohibit the Secretariat 
officers providing information received in the course of their duties to the Secretary’s delegate 
under the same Act for the purpose of the exercise of functions under that Act, even though 
that delegate is located in a different government agency provided the information is relevant 
to the function. 
2.15 The independent survey information was not personal information; it was not obtained 
from any ‘third person’ on the basis of it being for a particular purpose and the information 
concerned the distance between two locations, which were accessible to the public in any 
event. The only information the survey may have contained which could be described as 
‘information with respect to the affairs of a third person’ would be the implied existence of an 
application from a proprietor of a pharmacy in one of the locations it referenced. While this 
information could not be released to the public at large without consent, it does not seem 
impermissible to release it to the Secretary’s delegate for the purpose of completing the 
decision making process. DHS already had an awareness of the applications from its role in 
the receipt of applications. DoH advised its officers were also concerned that the independent 
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survey might ‘infect’ the decision-making process in respect of pharmacy X, because it had 
been obtained to resolve a question arising in a different application. In our view this would 
only arise if the independent survey were irrelevant to the issues to be decided in respect of 
pharmacy X, which it was not. The independent survey measured the actual distance between 
the locations of pharmacies X and Y and was relevant to both applications. Should the 
delegate have decided to have regard to the information, which was adverse to the interests 
of an applicant, it would have been necessary to afford that applicant an opportunity to 
comment on the information. However, this was a not an impediment to DoH advising the 
delegate of the independent survey. 
2.16 In establishing administrative procedures for the shared delivery of a program across 
more than one agency, consideration should be given in advance to any impediments to 
dividing the responsibilities for delivery of the program, such as any limitations that might 
prevent sharing of information. In this case the staff in DoH were uncertain whether they could 
advise the delegate in DHS about relevant information. Unfortunately, the time taken to obtain 
formal advice about sharing information meant that it was too late to prevent an incorrect 
decision being made and critically delayed service recovery action.  
Recommendation 2 
Where more than one agency is engaged in the delivery of a program, administrative 
processes should ensure that decision-making is not fragmented, that all decision-makers are 
able to receive all information relevant to a decision, and that staff training material refers to 
the provision of information to participants engaged in program decision-making located in 
other agencies. 
Service recovery  
2.17 Service recovery is one way of managing the risk of error in the delivery of government 
programs. In this report ‘service recovery’ refers to an agency’s response to risks that 
materialise and systemic and individual problems that arise in the delivery of services to the 
public. In the experience of the Ombudsman’s office, few programs are amenable to perfect 
administration and it follows that good administration of a program includes the recognition 
that service recovery is a central part of program delivery. Consequently, in implementing any 
program, regard should be had to potential service recovery issues, such as: 
• what issues are likely to arise? 
• who might be affected by the program or complain? 
• who is best placed to remediate any problems or handle complaints? 
• do those officers have the appropriate authorisations?  
• what contact arrangements, tools, training or other materials are required?  
• how to ensure that people (staff and the public) know or can easily find out about a 
service recovery process? 
• how to ensure that information obtained from service recovery experiences are drawn 
on for future service improvements? 
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2.18 A number of service recovery issues were identified in the investigation of this 
complaint, including: 
• the Secretariat identified the error, but did not take timely action to prevent the error 
having consequential effects, while it was deciding how to respond; 
• the Secretariat did not identify all parties potentially affected by the error; 
• when Mr C identified himself as a person affected by the error, the agencies acted 
defensively and did not acknowledge or take responsibility for the error or its 
resolution. 
Immediate service recovery action to prevent consequential effects of error 
2.19 The Secretariat suspected that Mr X’s survey might have been incorrect on 
9 November 2011, when it requested the independent survey. However, there is no evidence 
that action was taken at that time to check whether or not the ACPA’s recommendation to 
approve Mr X’s application (which had been returned to DHS), had been actioned and, if not, 
of advice to the delegate that they may wish to delay deciding the matter.  
2.20 Similarly, there is no evidence to suggest that action was taken to check the progress 
of the approval process with DHS or advise of the need for clarification when, on 23 
December 2011, the independent survey confirmed the error. 
2.21 Ordinarily, once a decision-maker is ready to make a decision, it should be made 
without further delay, unless there is a good reason not to do so. In this case the Secretariat 
had a reasonable basis by 23 December 2011 (two surveys by registered surveyors) on which 
to suspect that a material piece of information before the decision-maker was incorrect and 
could result in an incorrect decision. That is, there was a good reason to request that the 
delegate delay making the decision while the Secretariat, acting in a timely manner, clarified 
the options. As explained at paragraph 2.14, it would not have been unlawful for DoH to 
request that the DHS delegate delay their decision or, indeed in our view, to advise them of 
the independent survey. 
2.22 However, the Secretariat did not balance the risk of the consequences of advising the 
delegate to delay the decision against the risk of the delegate making an incorrect decision in 
the absence of such advice. Instead, the Secretariat allowed the risk of an incorrect approval 
decision being made to continue while it sought the independent survey and, later, while it 
sought legal advice.  
2.23 The risk for DoH in advising the delegate in DHS to delay its decision was that, if this 
proved ultimately unnecessary, the applicant might complain about the delay and, if that delay 
were of an unreasonable duration, claim that the new business had lost profits. On the other 
hand the risk for DoH of failing to advise was that an incorrect decision would be made which, 
while favouring the applicant, could affect surrounding pharmacies and the reputation of the 
program. 
Identifying who was potentially affected by the error 
2.24 Balancing the risks of whether or not to advise the delegate immediately would have 
included consideration of who was likely to be affected by each option and how. In this case, it 
was likely to have led to the identification of Mr C as a potentially affected person. This is 
because the distance between pharmacy C and pharmacy X was included in the (incorrect) 
survey that Mr X provided in support of his application.  
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2.25 While, we do not know exactly why the Secretariat or other DoH staff did not suggest 
the delay of the delegate’s decision on 23 December 2011, we note that this is consistent with 
the subsequent defensive approach that DoH took in response to Mr C’s complaint. 
Taking responsibility for errors 
 
2.26 Once the Secretariat became aware that the delegate in DHS had sent the approval to 
the applicant, the Secretariat would appear to have done nothing further to minimise any 
consequences of the error for the public. When Mr C identified himself as a person adversely 
affected by the approval and queried the basis for it, six weeks after the decision had been 
made, the Secretariat provided him with inadequate advice and declined to provide him with 
the reasons for its decision. 
2.27 It was not until June 2012 that one of the agencies (DHS) sought legal advice about 
what could be done to remedy the matter. By this time it was too late for an administrative 
revocation of the decision, as Mr X had relied upon the decision for some 6 months and could 
potentially himself have been aggrieved by any revocation of the decision. In July 2012, after 
receiving advice from Officer Q confirming the date of receipt of the independent survey, DHS 
sought advice [and concluded it would be appropriate to take no action …] unless another 
party took proceedings in court. 
2.28 While both DoH and DHS advised Mr C to seek legal advice, neither agency admitted, 
explained nor apologised for the error. We do not believe that this was an appropriate 
response, particularly when Mr C provided a further survey at his own expense, as evidence 
in support of his complaint that the decision to approve pharmacy X was based on incorrect 
information.  
2.29 Indeed DHS’ response to Mr C, written after consultation with DoH, appears to have 
been carefully worded to advise only that the information before the delegate in DHS on the 
date of the decision supported that decision, with no mention that elsewhere in the decision-
making chain (at the Secretariat) there had existed information to the contrary. While DHS 
advises that it considered this was a matter for DoH, these actions prolonged and 
exacerbated Mr C’s frustration. On the one hand, it was left to him to bear the risk of court 
proceedings to remedy the error. On the other hand, the agencies declined to give him all of 
the necessary information to seek advice on his prospects of success. 
2.30 In our view, the complaint handling aspect of service recovery in this matter was made 
more difficult by the cross agency nature of the program. DoH did not identify Mr C’s request 
for a statement of reasons as a complaint. While Mr C’s complaint was entertained by DHS, 
that agency did not possess all of the information to fully respond to the complaint. 
Recommendation 3 
A joint service recovery process should be developed for the pharmacy location program if it 
continues to be delivered across more than one agency. 
If the program is delivered by a single agency, that agency should have a service recovery 
process that applies to the pharmacy location program. 
Staff should be made aware of the service recovery process. 
Information about how to complain about the program, consistent with the service recovery 
process, should be available to the public. 
2.31 This investigation also raised concerns about the prominence that service recovery is 
given in DoH. In our view, the DoH’s approach to service recovery and complaint handling 
veered between cautious and defensive and led to missed opportunities for resolution.  
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2.32 With the benefit of hindsight, and as an outside observer, it is apparent that DoH could 
have prevented or delayed the approval by promptly contacting the delegate in DHS. 
However, the Secretariat officers appear to have lacked the confidence to take any action 
without legal advice, even where this may have led to a wrong decision affecting others being 
made in the meantime. While we acknowledge that DoH was concerned about what it 
describes as ‘the litigious nature of the sector’, the lesson from this case study is the 
importance of a culture that supports staff to take preventative action, and to try to mitigate 
errors, even where they may do so imperfectly. 
Recommendation 4 
DoH promote a service recovery culture within the agency and ensure that its officers have 
appropriate delegation or escalation avenues for timely service recovery and are aware that 
service recovery activities will be supported. 
  
Page 20 of 26 
 
Commonwealth Ombudsman—Department of Health: Avoiding, acknowledging and fixing mistakes—
04/2014 (abridged) 
 
 
PART 3—CONCLUSION AND RECOMMENDATIONS 
3.1 This investigation report provides a case study on the consequences of failure to 
incorporate service recovery into the framework of program delivery design. The 
consequences of a lack of support for service recovery culture and the role that complaint 
handling plays within service recovery is also demonstrated. This was particularly evident in 
the cautious actions of the officers in the ACPA Secretariat, who initially lacked the authority 
or confidence to take immediate remedial action in the absence of legal advice, despite the 
fact that this compromised the objectives of the program in that an incorrect decision 
prevailed; and later defended the reputation of the agency, rather than responding to the 
complainant in a fair and open manner. We do not mean this as a comment on any 
individuals, but rather on the scope of the role they occupied and constraints implied by 
agency culture. 
3.2 We accept that to empower officers to take the initiative to respond to service failings 
where, as in this case, circumstances require timely action and an evaluation has to be made 
(possibly by someone not used to doing so) between imperfect options, carries a risk that the 
response will not be the one that a fully informed more senior officer may have made. 
However, as this report shows, to do nothing also carries risk.  
3.3 Moreover, an approach to complainants that is less than fair and open does not 
enhance an agency’s reputation. In the Ombudsman’s experience, a complainant and those 
to whom his story is conveyed, is likely to complete the missing parts of the story with 
assumptions which may be less favourable than the explanation which could have been 
provided by the agency itself. Further the person’s unsatisfactory experience with the agency 
will be aggravated and prolonged if they believe that they have been ‘brushed off’. 
3.4 To address the shortcomings we have identified in our investigation of Mr C’s 
complaint, we make the following four recommendations:  
Recommendation 1 
A consultation process with potentially impacted pharmacies is developed to enable the 
receipt of comments on an application prior to the making of a recommendation or decision on 
that application. 
3.5 This recommendation recognises that the relevant legislation gave very little scope for 
the correction of an erroneous decision by administrative means. In such contexts the 
administrative processes leading up to a decision should include steps to minimise error, such 
as consultation processes, regardless of whether these are legal preconditions to the making 
of the decision. We note DoH has already taken steps in relation to the quality of survey 
evidence it will now accept. 
Recommendation 2 
Where more than one agency is engaged in the delivery of a program, administrative 
processes should ensure that decision-making is not fragmented, that all decision-makers are 
able to receive all information relevant to a decision, and that staff training material refers to 
the provision of information to participants engaged in program decision-making located in 
other agencies. 
3.6 This recommendation concerns the contribution of the cross agency design of the 
decision making process to the resulting decision which did not meet the objectives of the 
rules. The process unnecessarily fragmented access to information which was relevant to the 
decision. In the case at hand, officers hesitated to inform other officers involved in the 
decision making process that there was a significant matter regarding the recommendation 
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because, while operating under the same Act and program, those other officers were located 
in a different agency.  
Recommendation 3 
A joint service recovery process should be developed for the pharmacy location program if it 
continues to be delivered across more than one agency; 
If the program is delivered by a single agency, that agency should have a service recovery 
process that applies to the pharmacy location program; 
Staff should be made aware of the service recovery process. 
Information about how to complain about the program, consistent with the service recovery 
process, should be available to the public. 
3.7 Few programs are amenable to perfect delivery and good administration includes the 
recognition of this fact and a service recovery plan encompassing the handling of complaints. 
The third recommendation concerns the need for a joint service recovery process should the 
program continue to be delivered across more than one agency. If, in future, the program is 
delivered by a single agency, then a service recovery process should be devised in relation to 
the program.  
Recommendation 4 
DoH promote a service recovery culture within the agency and ensure that its officers have 
appropriate delegation or escalation avenues for timely service recovery and are aware that 
service recovery activities will be supported. 
3.8 The fourth recommendation concerns the need for a service recovery culture that we 
believe underscored the failure by the ACPA Secretariat within DoH to take responsibility for 
the error, take pro-active action to minimise any consequential effects and to consider and 
respond to the complainant’s reasonable concerns. Even where the agency may have been 
unable to correct the decision, we think it is appropriate to provide the complainant with an 
explanation and an apology. Consequently, we have recommended that steps be taken to 
support a service recovery culture within DoH. 
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PART 4— AGENCY RESPONSES  
4.1 A copy of this report was provided to the Secretaries of DoH and DHS for comment by 
those agencies. A copy was also provided to the Australian Government Solicitor to ensure 
that references to that body were correct. 
 
Comments and responses to recommendations provided by DoH 
A copy of the draft report was provided to the Department of Health on 14 November 2014 for 
comment. The Department’s comments on matters set out in the report have been taken into 
account in the body of the report.  
 
The Department provided comments on the recommendations in its letter reproduced below: 
 
I refer to your letter of 14 November 2014 and thank you for the opportunity to review and 
provide comments on the draft report Department of Health: Avoiding, acknowledging and 
fixing mistakes (the report). 
 
The Department is committed to accurate and effective decision-making.  Further, it works to 
ensure processes, particularly those that are outward-facing, evolve to maintain pace with 
changing provider practice and public governance.  For these reasons the Department 
welcomes the report as an opportunity to further review the processes of the Australian 
Community Pharmacy Authority (ACPA). 
 
May I acknowledge from the outset the professional and constructive way in which your officers 
have worked with the Department to progress this report. 
 
It may be useful to make some preliminary observations on the context in which the Australian 
Community Pharmacy Authority operates.  The Authority administers the pharmacy location 
rules determined by the Minister under the National Health Act 1953 in light of the five yearly 
agreements reached with the Pharmacy Guild of Australia.  Decisions must be made by the 
Authority in areas of great commercial sensitivity to pharmacists who compete against each 
other on a local geographic basis.  The Authority permits on the one hand access to the 
operation of pharmacies within a geographical area, whilst at the same time permitting new 
competition to existing pharmacies in the same areas.  The distances selected under the 
location rules are necessarily arbitrary.   Decisions of the Authority are frequently contentious, 
and often lead to challenges to decisions in the AAT.  During the period of the Fifth Community 
Pharmacy Agreement the Department has dealt with 70 matters in the AAT and 15 in the 
Federal Court, and provided 168 statements of reasons.   Accordingly, the Authority needs to 
deal with competing stakeholders in an even-handed manner, whilst at the same time 
conducting itself in a way which does not prejudice the interests of the Commonwealth and 
others should decisions lead to litigation.  The appropriate management of complaints need on 
the one hand to deal fairly and reasonably with stakeholders, whilst managing legal risk 
appropriately in a contentious and often litigious environment.  At the same time, staff need to 
ensure that information which is frequently commercially sensitive is managed in a way which 
does not infringe privacy constraints or the prohibitions contained in s.135A of the National 
Health Act.  This raises challenges for a complaints handling system which do not arise where 
a single party (with interests which do not conflict with the interests of any other individual) is 
concerned.  The Department is happy to review its complaints handling processes and 
procedures, but notes that this will need to be done against an often contentious and sensitive 
context,  in a way which ensures the information of all parties concerned is treated in line with 
legislative constraints, and in a way which does not  prejudice the position of the 
Commonwealth or individuals in any litigation which may result.   
 
As I noted previously, the Department welcomes, and is broadly supportive of, the 
recommendations in the report as an opportunity to improve processes in relation to the ACPA 
and the Department more generally.  I make the following additional observations about the 
individual recommendations.  
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Recommendation 1 – Consultation with nearby pharmacies: 
 
The report has identified that where possible, and with appropriate reference to the secrecy 
provisions of the Act, the ACPA secretariat makes significant efforts to ensure that surrounding 
pharmacists are provided the opportunity to comment on relevant applications, consistent with 
the obligations imposed on them under the Privacy Act and the confidentiality constraints set 
out in section 135A of the National Health Act.  The Department also notes the limitations of the 
existing pharmacy database and will investigate options for more frequent updates to the 
database to reflect approvals made by the delegate at DHS, or other means by which up-to-
date details of surrounding pharmacies can be obtained in a timely manner. 
 
Recommendation 2 – Cross agency decision-making process 
 
The Department accepts that improved information sharing between administrative and 
delivery agencies is likely to enhance the consistency of decision-making.  The Department will 
work with DHS to further enhance the connection between the agencies and ensure that 
documented systems are instituted to ensure information is shared in a timely manner to the 
extent practically and legally possible. 
 
Recommendation 3 – Service recovery 
 
While I note the report advocates for the ACPA administrative and delivery processes to be 
operated through a single agency, a decision to move functions between agencies is ultimately 
a matter for Government.  However, and in relation to service recovery processes for the ACPA 
and pharmacy approval processes generally, I suggest that enhanced communication between 
the Department and DHS outlined above, in addition to consideration of possible changes to 
the Act enabling reversal of an ACPA recommendation and subsequent approval where they 
have been made in error will significantly improve service recovery for this programme. 
 
Recommendation 4 – Departmental service recovery culture 
 
Both this report and the Capability Review of the Department by the Australian Public Service 
Commission released on 4 December 2014 provide an opportunity to take the Department 
forward, build the capability for the future and make the Department the best organisation it can 
be.  In particular the Department must address some inadequate governance arrangements 
and delivery frameworks and also foster a culture that that is open and appropriately embraces 
and manages risks within defined tolerances.  The Department is committed to achieving the 
necessary reforms, including service recovery, and understands this will require the 
contributions of all staff at all levels. 
 
Thank you again for providing the department an opportunity to comment on the draft report. 
 
Yours sincerely 
 
Martin Bowles PSM 
Secretary 
22 December 2014 
 
Comments and response to recommendations provided by DHS 
A copy of the draft report was provided to the Department of Human Services on 14 
November 2014 for comment. The Department's comments on matters set out in the report 
have been taken into account in the body of the report.  
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The Department provided the following comments on the recommendations: 
 
Recommendation   1 
 
The first recommendation is that a consultation process be established to enable potentially 
impacted pharmacies to make comments on an application prior to a recommendation or a 
decision being made in respect of the application. 
 
The department agrees that having a formal consultation process is likely to mitigate the risk of 
similar problems arising with respect to pharmacy approval processes going forward. However, 
the department submits that any consultation should occur only once, and would best occur 
prior to the ACPA making its recommendation in relation to an application. The department 
sees little merit in further consultation occurring after the ACPA has made its recommendation, 
noting that potentially impacted pharmacies could still make submissions to the department or 
the Department of Health following that recommendation but prior to the departmental 
delegate’s approval of the application 
 
Recommendation 2 
 
The second recommendation is that administrative processes should ensure that decision 
making is not fragmented, that all decision makers should receive information relevant to the 
making of decisions, and that training material should refer to relevant information being 
exchanged between decision makers in different agencies. 
 
The department agrees with this recommendation insofar as it relates to the exchange of 
relevant information. The department notes that decision making in relation to pharmacy 
approvals remains fragmented to some extent as a result of the applicable statutory framework, 
which provides for a two stage process involving different decision makers located in different 
agencies. 
 
Recommendation 3 
 
The third recommendation is that a joint service recovery process be developed in relation to 
the pharmacy approval application process. 
 
The department takes the view that service recovery processes should be in place to mitigate 
any potential risks identified with decision making processes associated with the approval of 
pharmacies to supply PBS medicines. The department therefore agrees that a service recovery 
process should be developed to address the particular deficiencies identified by this 
investigation, which centre on the failure of relevant information being considered by, and made 
available to, decision makers in the department and the Department of Health. 
 
Recommendation 4 
 
The department has no comment to make on the fourth recommendation, which is 
directed at the Department of Health. 
 
Thank you for giving the department an opportunity to comment on the draft report . 
 
Yours sincerely 
 
Kathryn Campbell 
} December 2014 
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APPENDIX 
Extract from Pharmacy Location Rules Applicant’s Handbook current at 2011 
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